Protein powders for encapsulation: A comparison of spray-freeze drying and spray drying of darbepoetin alfa

被引:45
作者
Nguyen, XC
Herberger, JD
Burke, PA
机构
[1] Amgen Inc, Pharmaceut & Drug Delivery, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Proc Dev, Thousand Oaks, CA 91320 USA
关键词
NESP; spray lyophilization; protein stability; protein encapsulation;
D O I
10.1023/B:PHAM.0000019306.89420.f0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To evaluate spray-freeze drying and spray drying processes for fabricating micron- sized particles of darbepoetin alfa (NESP, Aranesp(R)) with uniform size distribution and retention of protein integrity, requirements for encapsulation. Methods. Darbepoetin alfa was spray-freeze dried using ultrasonic atomization at 120 kHz and 25 kHz and spray dried at bench-top and pilot scales. Reconstituted powders were evaluated by size exclusion chromatography and UV/VIS spectroscopy. Powder physical properties were also characterized. Results. Spray-freeze drying resulted in aggregation of darbepoetin alfa. Aggregates ( primarily insoluble) formed on drying and/or reconstitution. Particle size distributions were broad (span greater than or equal to 3.6) at both nozzle frequencies. Annealing before drying reduced aggregate levels slightly but increased particle size over 5-fold. Spray drying at inlet temperatures up to 135degreesC (and outlet temperatures up to 95degreesC) showed little impact on integrity. Integrity at bench-top and pilot scales was identical, with 0.2% dimer and no high molecular weight or insoluble aggregates detected. Particle size was small (less than or equal to 2.3 mum) with uniform distribution (span less than or equal to 1.4) at both process scales. Conclusions. Under the conditions tested spray drying, conducted at bench-top and pilot scales with commercially available equipment, was superior to spray-freeze drying for the fabrication of darbepoetin alfa particles for encapsulation.
引用
收藏
页码:507 / 514
页数:8
相关论文
共 31 条
[1]   The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody [J].
Andya, JD ;
Maa, YF ;
Costantino, HR ;
Nguyen, PA ;
Dasovich, N ;
Sweeney, TD ;
Hsu, CC ;
Shire, SJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (03) :350-358
[2]  
Burke PA, 2000, HDB PHARM CONTROLLED, P661
[3]   Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery [J].
Chan, HK ;
Clark, A ;
Gonda, I ;
Mumenthaler, M ;
Hsu, C .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :431-437
[4]   Surface-induced denaturation of proteins during freezing and its inhibition by surfactants [J].
Chang, BS ;
Kendrick, BS ;
Carpenter, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1325-1330
[5]   AGGREGATION OF A LYOPHILIZED PHARMACEUTICAL PROTEIN, RECOMBINANT HUMAN ALBUMIN - EFFECT OF MOISTURE AND STABILIZATION BY EXCIPIENTS [J].
COSTANTINO, HR ;
LANGER, R ;
KLIBANOV, AM .
BIO-TECHNOLOGY, 1995, 13 (05) :493-496
[6]   Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability [J].
Costantino, HR ;
Firouzabadian, L ;
Wu, CC ;
Carrasquillo, KG ;
Griebenow, K ;
Zale, SE ;
Tracy, MA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (02) :388-395
[7]   Protein spray-freeze drying.: Effect of atomization conditions on particle size and stability [J].
Costantino, HR ;
Firouzabadian, L ;
Hogeland, K ;
Wu, CC ;
Beganski, C ;
Carrasquillo, KG ;
Córdova, M ;
Griebenow, K ;
Zale, SE ;
Tracy, MA .
PHARMACEUTICAL RESEARCH, 2000, 17 (11) :1374-1383
[8]  
Eckhardt B M, 1994, J Pharm Sci Technol, V48, P64
[9]   EFFECT OF FREEZING ON AGGREGATION OF HUMAN GROWTH-HORMONE [J].
ECKHARDT, BM ;
OESWEIN, JQ ;
BEWLEY, TA .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1360-1364
[10]   Development and characterization of novel erythropoiesis stimulating protein (NESP) [J].
Egrie, JC ;
Browne, JK .
BRITISH JOURNAL OF CANCER, 2001, 84 (Suppl 1) :3-10